Literature DB >> 32616526

Dramatic presentation of acquired TTP associated with COVID-19.

Marco Capecchi1, Cristina Mocellin2, Chiara Abbruzzese3, Ilaria Mancini4, Daniele Prati2, Flora Peyvandi5.   

Abstract

Keywords:  Infectious Disorders; SARS-CoV-2; Thrombotic Thrombocytopenic Purpura

Year:  2020        PMID： 32616526      PMCID： PMC7556657          DOI： 10.3324/haematol.2020.262345

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

1.  Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.

Authors:  Marie Scully; Spero R Cataland; Flora Peyvandi; Paul Coppo; Paul Knöbl; Johanna A Kremer Hovinga; Ara Metjian; Javier de la Rubia; Katerina Pavenski; Filip Callewaert; Debjit Biswas; Hilde De Winter; Robert K Zeldin
Journal:  N Engl J Med       Date:  2019-01-09       Impact factor: 91.245

Review 2.  Alveolar Hemorrhage in Vasculitis (Primary and Secondary).

Authors:  Mouhamad Nasser; Vincent Cottin
Journal:  Semin Respir Crit Care Med       Date:  2018-11-07       Impact factor: 3.119

Review 3.  Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.

Authors:  M Saha; J K McDaniel; X L Zheng
Journal:  J Thromb Haemost       Date:  2017-07-27       Impact factor: 5.824

4.  Complement activation in thrombotic thrombocytopenic purpura.

Authors:  M Réti; P Farkas; D Csuka; K Rázsó; Á Schlammadinger; M L Udvardy; K Madách; G Domján; C Bereczki; G S Reusz; A J Szabó; Z Prohászka
Journal:  J Thromb Haemost       Date:  2012-05       Impact factor: 5.824

5.  Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.

Authors:  Flora Peyvandi; Marie Scully; Johanna A Kremer Hovinga; Spero Cataland; Paul Knöbl; Haifeng Wu; Andrea Artoni; John-Paul Westwood; Magnus Mansouri Taleghani; Bernd Jilma; Filip Callewaert; Hans Ulrichts; Christian Duby; Dominique Tersago
Journal:  N Engl J Med       Date:  2016-02-11       Impact factor: 91.245

Review 6.  Thrombotic thrombocytopenic purpura.

Authors:  Bérangère S Joly; Paul Coppo; Agnès Veyradier
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

7.  Correlation between plasma activity of ADAMTS-13 and coagulopathy, and prognosis in disseminated intravascular coagulation.

Authors:  Jungwon Hyun; Hyun Kyung Kim; Ji-Eun Kim; Min-Gyu Lim; Jae Seol Jung; Seonyang Park; Han-Ik Cho
Journal:  Thromb Res       Date:  2009-01-21       Impact factor: 3.944

8.  Endothelial cell infection and endotheliitis in COVID-19.

Authors:  Zsuzsanna Varga; Andreas J Flammer; Peter Steiger; Martina Haberecker; Rea Andermatt; Annelies S Zinkernagel; Mandeep R Mehra; Reto A Schuepbach; Frank Ruschitzka; Holger Moch
Journal:  Lancet       Date:  2020-04-21       Impact factor: 79.321

9.  Complement activation in patients with COVID-19: A novel therapeutic target.

Authors:  Massimo Cugno; Pier Luigi Meroni; Roberta Gualtierotti; Samantha Griffini; Elena Grovetti; Adriana Torri; Mauro Panigada; Stefano Aliberti; Francesco Blasi; Francesco Tedesco; Flora Peyvandi
Journal:  J Allergy Clin Immunol       Date:  2020-05-14       Impact factor: 10.793
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.